A randomized, double-blind, placebo-controlled study to assess the efficacy and safety of cinacalcet in pediatric patients with chronic kidney disease and secondary hyperparathyroidism receiving dialysis

导出原文传递

翻译打印收藏纠错

作者： Warady, Bradley A. ^[1] ; Iles, Janet N. ^[2] ; Ariceta, Gema ^[3] ; Dehmel, Bastian ^[4] ; Hidalgo, Guillermo ^[5] ; Jiang, Xun ^[6] ; Laskin, Benjamin ^[7] ; Shahinfar, Shahnaz ^[8] ; Vande Walle, Johan ; Schaefer, Franz

作者单位： Amgen Europe GmbH, Zug, Switzerland ^[1] Amgen Inc, Thousand Oaks, CA 91320 USA ^[2] Heidelberg Univ Hosp, Heidelberg, Germany ^[3] Childrens Mercy Kansas City, Div Pediat Nephrol, 2401 Gillham Rd,2MOB 17, Kansas City, MO 64108 USA ^[4] East Carolina Univ, Brody Sch Med, Greenville, NC USA ^[5] Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA ^[6] Univ Ghent, Ghent, Belgium ^[7] Univ Hosp Vall dHebron, Barcelona, Spain ^[8]

关键词 Calcimimetics Chronic kidney disease Cinacalcet Parathyroid hormone Pediatric patients Secondary hyperparathyroidism

发布时间 2019-07-27

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交